The CDC's Kentucky research study of COVID infection was designed to sell the vaccination program. On Aug 6, 2021 the CDC presented a paper titled “Reduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination -- Kentucky, May–June 2021.” Having spent the last two decades in the pharmaceutical industry, I’m well versed in spotting studies whose primary purpose is to sell a product instead of actually advancing science. I believe that is the case here. On the surface, the CDC’s paper appears to be straightforward: they did a statistical analysis of people in Kentucky who previously had COVID-19 and later were...